Keita Pharma Private Limited, a active private limited company, was established on 06 December 2010 in Navi Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U33100MH2010PTC210627. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Dinesh Baliram Gursale (Director), Poonam Dinesh Gursale (Director). Past directors included Ishwari Devdutt Dhikle. It holds ₹4.11 M open charges and ₹2.40 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Office No.B/401,Technocity,Plot No.X-4/1 & X-4/2 4Th Floor, Midc Ttc Industrial Area,Maha, Pe, Navi Mumbai, Maharashtra, 400710.
U33100MH2010PTC210627
210627
06 December 2010
₹0.10 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Keita Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Dinesh Baliram Gursale | Director | 06 Dec 2010 | Current |
| Poonam Dinesh Gursale | Director | 10 Aug 2016 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 28 Jan 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Keita Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 16.5% increase. The company also saw a substantial fall in profitability, with a 31.11% decrease in profit. The company's net worth Soared by an impressive increase of 25.91%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Keita Pharma had a promoter holding of 99.90% and a public holding of 0.10%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹4,108,958.00
₹23,989,500.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Aug 2023 | Hdfc Bank Limited | ₹1.51 M | Open |
| 04 Apr 2022 | Axis Bank Limited | ₹2.60 M | Open |
| 16 Sep 2022 | State Bank Of India | ₹1.00 Cr | Satisfied |
| 31 Mar 2021 | Others | ₹3.99 M | Satisfied |
| 31 Dec 2020 | Others | ₹1.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Keita Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Keita Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Keita Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Keita Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on A charge registered on 31 Mar 2021 via Charge ID 100456290 with Others was fully satisfied on 08 May 2024. was documented.
Progress on A charge registered on 16 Sep 2022 via Charge ID 100615107 with State Bank Of India was fully satisfied on 16 Apr 2024. was documented.
Keita Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 1.51 M with Charge ID 100783530 was registered on 24 Aug 2023. was documented.
Progress on A charge registered on 31 Dec 2020 via Charge ID 100414750 with Others was fully satisfied on 05 Jan 2023. was documented.
The CIN of Keita Pharma Private Limited is U33100MH2010PTC210627.
Keita Pharma Private Limited is headquartered at Office No.B/401,Technocity,Plot No.X-4/1 & X-4/2 4Th Floor, Midc Ttc Industrial Area,Maha, Pe, Navi Mumbai, Maharashtra, 400710.
Keita Pharma Private Limited was incorporated on 06 December 2010.
The current directors of Keita Pharma Private Limited are
The primary industry of Keita Pharma Private Limited is Manufacturing.
Keita Pharma Private Limited is unlisted.
The authorized capital of Keita Pharma Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Keita Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX